| Muneer A. Satter |
|
830466 |
0 |
830466 |
0 |
830466 |
4.9 % |
16/04/2024 |
| The University of Texas/Texas A&M Investment Management Company |
TX |
0 |
1812627 |
0 |
1812627 |
1812627 |
6.2 % |
06/03/2024 |
| Muneer A. Satter |
|
1017033 |
0 |
1017033 |
0 |
1017033 |
5.9 % |
05/03/2024 |
| BVF Partners OS Ltd. |
|
0 |
0 |
0 |
0 |
0 |
0 % |
14/02/2024 |
| BVF Inc. |
|
0 |
0 |
0 |
0 |
0 |
0 % |
14/02/2024 |
| BVF Partners L.P. |
|
0 |
0 |
0 |
0 |
0 |
0 % |
14/02/2024 |
| BVF GP Holdings LLC |
|
0 |
0 |
0 |
0 |
0 |
0 % |
14/02/2024 |
| BVF II GP LLC |
|
0 |
0 |
0 |
0 |
0 |
0 % |
14/02/2024 |
| Biotechnology Value Fund II, L.P. |
|
0 |
0 |
0 |
0 |
0 |
0 % |
14/02/2024 |
| BVF I GP LLC |
|
0 |
0 |
0 |
0 |
0 |
0 % |
14/02/2024 |
| Biotechnology Value Fund, L.P. |
|
0 |
0 |
0 |
0 |
0 |
0 % |
14/02/2024 |
| Mark N. Lampert |
|
0 |
0 |
0 |
0 |
0 |
0 % |
14/02/2024 |
| Biotechnology Value Trading Fund OS LP |
|
0 |
0 |
0 |
0 |
0 |
0 % |
14/02/2024 |
| Scott B. Kapnick |
United States of America |
0 |
0 |
0 |
0 |
0 |
0 % |
05/02/2024 |
| BIOS LTI CO-INVEST III, LP |
DELAWARE, UNITED STATES |
0 |
536182 |
0 |
0 |
536182 |
9.99 % |
13/11/2023 |
| BIOS CAPITAL MANAGEMENT, LP |
TEXAS, UNITED STATES |
0 |
521016 |
0 |
0 |
521016 |
9.99 % |
13/11/2023 |
| CAVU ADVISORS, LLC |
TEXAS, UNITED STATES |
0 |
521016 |
0 |
0 |
521016 |
9.99 % |
13/11/2023 |
| BIOS ADVISORS GP, LLC |
TEXAS, UNITED STATES |
0 |
521016 |
0 |
0 |
521016 |
9.99 % |
13/11/2023 |
| AARON GLEN LOUIS FLETCHER |
UNITED STATES |
10540 |
509306 |
10540 |
0 |
519846 |
9.99 % |
13/11/2023 |
| LESLIE WAYNE KREIS, JR. |
UNITED STATES |
1819 |
518995 |
1819 |
0 |
520814 |
9.99 % |
13/11/2023 |
| BIOS FUND I, LP |
DELAWARE, UNITED STATES |
0 |
539293 |
0 |
0 |
539293 |
9.99 % |
13/11/2023 |
| BIOS EQUITY PARTNERS II, LP |
TEXAS, UNITED STATES |
0 |
527239 |
0 |
0 |
527239 |
9.99 % |
13/11/2023 |
| BIOS EQUITY PARTNERS III, LP |
TEXAS, UNITED STATES |
0 |
542256 |
0 |
0 |
542256 |
9.99 % |
13/11/2023 |
| CAVU MANAGEMENT, LP |
TEXAS, UNITED STATES |
0 |
521016 |
0 |
0 |
521016 |
9.99 % |
13/11/2023 |
| BIOS FUND I QP, LP |
DELAWARE, UNITED STATES |
0 |
540039 |
0 |
0 |
540039 |
9.99 % |
13/11/2023 |
| BIOS EQUITY PARTNERS, LP |
TEXAS, UNITED STATES |
0 |
536033 |
0 |
0 |
536033 |
9.99 % |
13/11/2023 |
| BIOS LTI CO-INVEST III QP, LP |
DELAWARE, UNITED STATES |
0 |
536029 |
0 |
0 |
536029 |
9.99 % |
13/11/2023 |
| BIOS FUND II QP, LP |
DELAWARE, UNITED STATES |
0 |
540370 |
0 |
0 |
540370 |
9.99 % |
13/11/2023 |
| BIOS FUND III, LP |
DELAWARE, UNITED STATES |
0 |
178500 |
0 |
0 |
178500 |
3.52 % |
13/11/2023 |
| BIOS FUND III QP, LP |
DELAWARE, UNITED STATES |
0 |
542256 |
0 |
0 |
542256 |
9.99 % |
13/11/2023 |
| BIOS FUND II, LP |
DELAWARE, UNITED STATES |
0 |
332278 |
0 |
0 |
332278 |
6.37 % |
13/11/2023 |
| BIOS CLINICAL OPPORTUNITY FUND, LP |
DELAWARE, UNITED STATES |
0 |
542256 |
0 |
0 |
542256 |
9.99 % |
13/11/2023 |
| BIOS FUND III NT, LP |
DELAWARE, UNITED STATES |
0 |
187500 |
0 |
0 |
187500 |
3.7 % |
13/11/2023 |
| BIOS FUND II NT, LP |
DELAWARE, UNITED STATES |
0 |
144365 |
0 |
0 |
144365 |
2.87 % |
13/11/2023 |
| BIOS LTI SPV II, LP |
DELAWARE, UNITED STATES |
0 |
540023 |
0 |
0 |
540023 |
9.99 % |
13/11/2023 |
| BIOS EQUITY COF, LP |
TEXAS, UNITED STATES |
0 |
542256 |
0 |
0 |
542256 |
9.99 % |
13/11/2023 |
| Muneer A. Satter |
|
1007488 |
0 |
1007488 |
0 |
1007488 |
19.9 % |
03/11/2023 |
| BVF Partners L.P. |
|
0 |
0 |
0 |
236835 |
236835 |
5.2 % |
14/02/2023 |
| Mark N. Lampert |
|
0 |
0 |
0 |
236835 |
236835 |
5.2 % |
14/02/2023 |
| Biotechnology Value Trading Fund OS LP |
|
0 |
0 |
0 |
11042 |
11042 |
1 % |
14/02/2023 |
| BVF Inc. |
|
0 |
0 |
0 |
236835 |
236835 |
5.2 % |
14/02/2023 |
| BVF GP Holdings LLC |
|
0 |
0 |
0 |
222610 |
222610 |
4.9 % |
14/02/2023 |
| BVF Partners OS Ltd. |
|
0 |
0 |
0 |
11042 |
11042 |
1 % |
14/02/2023 |
| Biotechnology Value Fund, L.P. |
|
0 |
0 |
0 |
125755 |
125755 |
2.8 % |
14/02/2023 |
| BVF I GP LLC |
|
0 |
0 |
0 |
125755 |
125755 |
2.8 % |
14/02/2023 |
| Biotechnology Value Fund II, L.P. |
|
0 |
0 |
0 |
96855 |
96855 |
2.1 % |
14/02/2023 |
| BVF II GP LLC |
|
0 |
0 |
0 |
96855 |
96855 |
2.1 % |
14/02/2023 |
| Scott B. Kapnick |
United States of America |
379608 |
0 |
379608 |
0 |
379608 |
8.4 % |
14/02/2023 |
| Scott B. Kapnick |
|
7592222 |
0 |
7592222 |
0 |
7592222 |
8.4 % |
14/02/2022 |
| BVF Inc. |
Delaware |
0 |
0 |
0 |
5265555 |
5265555 |
6.3 % |
19/01/2021 |
| Mark N. Lampert |
Delaware |
0 |
0 |
0 |
5265555 |
5265555 |
6.3 % |
19/01/2021 |
| Biotechnology Value Fund II, L.P. |
Delaware |
0 |
0 |
0 |
2047487 |
2047487 |
2.5 % |
19/01/2021 |
| BVF II GP LLC |
Delaware |
0 |
0 |
0 |
2047487 |
2047487 |
2.5 % |
19/01/2021 |
| BVF GP HOLDINGS LLC |
Delaware |
0 |
0 |
0 |
4827023 |
4827023 |
5.8 % |
19/01/2021 |
| BVF Partners OS Ltd. |
Delaware |
0 |
0 |
0 |
335997 |
335997 |
1 % |
19/01/2021 |
| BVF Partners L.P. |
Delaware |
0 |
0 |
0 |
5265555 |
5265555 |
6.3 % |
19/01/2021 |
| Biotechnology Value Trading Fund OS LP |
Delaware |
0 |
0 |
0 |
335997 |
335997 |
1 % |
19/01/2021 |
| BVF I GP LLC |
Delaware |
0 |
0 |
0 |
2779536 |
2779536 |
3.3 % |
19/01/2021 |
| Biotechnology Value Fund, L.P. |
Delaware |
0 |
0 |
0 |
2779536 |
2779536 |
3.3 % |
19/01/2021 |
| Scott B. Kapnick |
United State of America |
3377222 |
0 |
3377222 |
0 |
3377222 |
8.8 % |
08/06/2020 |
| Novartis AG |
|
0 |
1199904 |
0 |
11 |
1199904 |
4.31 % |
16/04/2020 |
| Novartis Bioventures Ltd. |
|
0 |
1199904 |
0 |
11 |
1199904 |
4.31 % |
16/04/2020 |
| Novartis Bioventures Ltd. |
|
0 |
1572285 |
0 |
11 |
1572285 |
5.65 % |
13/04/2020 |
| Novartis AG |
|
0 |
1572285 |
0 |
11 |
1572285 |
5.65 % |
13/04/2020 |
| Novartis Bioventures Ltd. |
|
0 |
1882119 |
0 |
11 |
1882119 |
6.77 % |
18/03/2020 |
| Novartis AG |
|
0 |
1882119 |
0 |
11 |
1882119 |
6.77 % |
18/03/2020 |
| Steven Boyd |
|
0 |
1460620 |
0 |
1460620 |
1460620 |
4.99 % |
14/02/2020 |
| Armistice Capital, LLC |
|
0 |
1460620 |
0 |
1460620 |
1460620 |
4.99 % |
14/02/2020 |
| Armistice Capital Master Fund Ltd. |
|
0 |
1460620 |
0 |
1460620 |
1460620 |
4.99 % |
14/02/2020 |
| Lilly Ventures Fund I, LLC |
Delaware |
0 |
1094987 |
0 |
10 |
1094987 |
3.9 % |
13/08/2019 |
| Armen B. Shanafelt, Ph.D. |
Delaware |
0 |
1094987 |
0 |
10 |
1094987 |
3.9 % |
13/08/2019 |
| Steven E. Hall, Ph.D. |
Delaware |
0 |
1094987 |
0 |
10 |
1094987 |
3.9 % |
13/08/2019 |
| LV Management Group, LLC |
Delaware |
0 |
1094987 |
0 |
10 |
1094987 |
3.9 % |
13/08/2019 |
| S. Edward Torres |
Delaware |
0 |
1094987 |
0 |
10 |
1094987 |
3.9 % |
13/08/2019 |
| Armistice Capital Master Fund Ltd. |
Delaware |
0 |
2137089 |
0 |
2137089 |
2137089 |
8 % |
08/04/2019 |
| Armistice Capital, LLC |
Delaware |
0 |
2137089 |
0 |
2137089 |
2137089 |
8 % |
08/04/2019 |
| Steven Boyd |
Delaware |
0 |
2137089 |
0 |
2137089 |
2137089 |
8 % |
08/04/2019 |
| Lilly Ventures Fund I, LLC |
Delaware |
0 |
1094987 |
0 |
10 |
1094987 |
7.4 % |
17/07/2017 |
| Armen B. Shanafelt, Ph.D. |
United States |
0 |
1094987 |
0 |
10 |
1094987 |
7.4 % |
17/07/2017 |
| S. Edward Torres |
United States |
0 |
1094987 |
0 |
10 |
1094987 |
7.4 % |
17/07/2017 |
| LV Management Group, LLC |
Delaware |
0 |
1094987 |
0 |
10 |
1094987 |
7.4 % |
17/07/2017 |
| Steven E. Hall, Ph.D. |
United States |
0 |
1094987 |
0 |
10 |
1094987 |
7.4 % |
17/07/2017 |